CD8A and COVID-19: In the present study, no significant difference in the total number of NK cells and lymphocytes was observed between patients with moderate COVID‐19 and control patients (Figure 2A); the same was observed in the number of CD4+ T, CD8+ T and B cells (Figure 2C‐E).